Mitigating financial toxicity among us patients with cancer
Menée aux Etats-Unis à partir de données portant sur 1 409 patients atteints de cancer et bénéficiaires du système d'assurance maladie Medicare (âge médian : 73 ans), cette étude analyse les coûts restant à leur charge
Treatment for cancer is undergoing a renaissance. However, the “financial toxicity” of cancer treatment for US patients and their families is a growing concern.1 Financial distress among patients with cancer includes high out-of-pocket (OOP) spending relative to income and assets, loss of work, and significant household debt. Financial distress is associated with growing reports of delayed initiation of treatment, limited patient adherence, and abandonment of recommended treatment, which erodes the effectiveness of cancer treatment and even hastens death.
JAMA Oncology , commentaire, 2015